pp60c-Src phosphorylates and activates vacuolar protein sorting 34 to mediate cellular transformation

Cancer Research

Volumn 70, Issue 14, 2010, Pages 5974-5983

  Hirsch, Dianne S ^a   Shen, Yi ^a   Dokmanovic, Milos ^a   Wu, Wen Jin ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; PROTEIN KINASE P60; PROTEIN VPS 34; UNCLASSIFIED DRUG; TYROSINE;

ANIMAL CELL; ARTICLE; BREAST CANCER; CARCINOGENESIS; CELL TRANSFORMATION; COLONY FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE MUTATION; MAMMAL CELL; MULTINUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; ANIMAL; BIOSYNTHESIS; CELL STRAIN 3T3; CELL STRAIN COS1; CERCOPITHECUS; GENETICS; HUMAN; LIPID METABOLISM; METABOLISM; MOLECULAR GENETICS; MOUSE; PHOSPHORYLATION; PHYSIOLOGY; POINT MUTATION; TUMOR CELL LINE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CERCOPITHECUS AETHIOPS; COS CELLS; HUMANS; LIPID METABOLISM; MICE; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; PHOSPHORYLATION; POINT MUTATION; PROTO-ONCOGENE PROTEINS PP60(C-SRC); TYROSINE;

EID: 77955015995     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-2682     Document Type: Article

References (36)

1. Bader AG, Kang S, Zhao L, Vogt PK. Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer 2005;5:921-9. (Pubitemid 41766781)
2. Backer JM. The regulation and function of class III PI3Ks: novel roles for Vps34. Biochem J 2008;410:1-17.
3. Stack JH, Emr SD. Vps34p required for yeast vacuolar protein sorting is a multiple specificity kinase that exhibits both protein kinase and phosphatidylinositol-specific PI 3-kinase activities. J Biol Chem 1994;269:31552-62.
4. Nielsen E, Severin F, Backer JM, Hyman AA, Zerial M. Rab5 regulates motility of early endosomes on microtubules. Nat Cell Biol 1999;1:376-82. (Pubitemid 129493581)
5. Murray JT, Panaretou C, Stenmark H, Miaczynska M, Backer JM. Role of Rab5 in the recruitment of hVps34/p150 to the early endosome. Traffic 2002;3:416-27. (Pubitemid 34746409)
6. Vieira OV, Botelho RJ, Rameh L, et al. Distinct roles of class I and class III phosphatidylinositol 3-kinases in phagosome formation and maturation. J Cell Biol 2001;155:19-25. (Pubitemid 34286204)
7. Slessareva JE, Routt SM, Temple B, Bankaitis VA, Dohlman HG. Activation of the phosphatidylinositol 3-kinase Vps34 by a G protein á subunit at the endosomes. Cell 2006;126:191-203.
8. Petiot A, Ogier-Denis E, Blommaart EF, Meijer AJ, Codogno P. Distinct classes of phosphatidylinositol 3′-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J Biol Chem 2000;275:992-8. (Pubitemid 30051145)
9. Nobukuni T, Kozma SC, Thomas G. hVps34, an ancient player, enters a growing game: mTOR complex 1/S6K1 signaling. Curr Opin Cell Biol 2007;19:135-41.
10. Byfield MP, Murray JT, Backer JM. hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase. J Biol Chem 2005;280:33076-82.
11. Nobukuni T, Joaquin M, Roccio M, et al. Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. Proc Natl Acad Sci U S A 2005;102:14238-43. (Pubitemid 41429682)
12. Dann SG, Selvaraj A, Thomas G. mTOR complex 1-6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol Med 2007;13:252-9.
13. Okkenhaug K, Vanhaesebroeck B. New responsibilities for the PI3K regulatory subunit p85á. Sci STKE 2001;65:1-5.
14. Rodriguez-Viciana P, Warne PH, Dhand R, et al. Phosphatidylinositol- 3-OH kinase as a direct target of Ras. Nature 1994;370:527-32. (Pubitemid 24264918)
15. Rodriguez-Viciana P, Warne PH, Vanhaesebroeck B, Waterfield MD, Downward J. Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation. EMBO J 1996;15:2442-51. (Pubitemid 26151184)
16. Christoforidis S, Miaczynska M, Ashman K, et al. Phosphatidylinositol- 3-OH kinases are Rab5 effectors. Nat Cell Biol 1999;4:249-52. (Pubitemid 129500945)
17. Ishizawar R, Parsons SJ. c-Src and cooperating partners in human cancer. Cancer Cell 2004;6:209-14. (Pubitemid 39222033)
18. Thomas SM, Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 1997;13:513-609.
19. Biscardi JS, Ishizawar RC, Silva CM, Parsons SJ. Tyrosine kinase signaling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer. Breast Cancer Res 2000;2: 203-10.
20. Irby RB, Yeatman TJ. Role of Src expression and activation in human cancer. Oncogene 2000;19:5636-42.
21. Tuhackova Z, Sovova V, Sloncova E, Proud CG. Rapamycin-resistant phosphorylation of the initiation factor-4E-binding protein (4E-BP1) in v-src transformed hamster fibroblasts. Int J Cancer 1999;81:963-9. (Pubitemid 29249984)
22. Shah OJ, Kimball SR, Jefferson LS. The Src-family tyrosine inhibitor PP1 interferes with the activation of ribosomal protein S6 kinase. Biochem J 2002;366:57-62.
23. Penuel E, Martin GS. Transformation by v-src: Ras-MAPK and PI3K-mTOR mediate parallel pathways. Mol Biol Cell 1999;10: 1693-703. (Pubitemid 29272625)
24. Wu WJ, Lin R, Cerione RA, Manor D. Transformation activity of Cdc42 requires a region unique to Rho-related proteins. J Biol Chem 1998;273:16655-8.
25. Wu WJ, Tu S, Cerione RA. Activated Cdc42 sequesters c-Cbl and prevents EGFR degradation. Cell 2003;114:715-25.
26. Lin R, Bagrodia S, Cerione R, Manor DA. Novel Cdc42Hs mutant induces cellular transformation. Curr Biol 1997;7:794-7.
27. Siddhanta U, McIlroy J, Shah A, Zhang Y, Backer JM. Distinct roles for the p110a and hVPS34 phosphatidylinositol 3′-kinases in vesicular trafficking, regulation of the actin cytoskeleton, and mitogenesis. J Cell Biol 1998;143:1647-59.
28. Ruderman NB, Kapeller R, White MF, Cantley LC. Activation of phosphatidylinositol 3-kinase by insulin. Proc Natl Acad Sci U S A 1990;87:1411-5.
29. Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with Image J. Biophotonics Int 2004;11:36-42.
30. Hirsch DS, Shen Y, Wu WJ. Growth and motility inhibition of breast cancer cells by epidermal growth factor receptor degradation is correlated with inactivation of Cdc42. Cancer Res 2006;66: 3523-30.
31. Shaw RJ, Cantley LC. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 2006;441:424-30.
32. Huang HD, Lee TY, Tseng SW, Horng JT. KinasePhos: a web tool identifying protein kinase-specific phosphorylation sites. Nucleic Acids Res 2005;33:W226-9.
33. Sagona AP, Nezis IP, Pedersen NM, et al. PtdIns(3)P controls cytokinesis through KIF13A-mediated recruitment of FYVE-CENT to the midbody. Nat Cell Biol 2010;12:362-71.
34. Stack JH, Herman PK, Schu PV, Emr SD. A membrane-associated complex containing the Vps15 protein kinase and the Vps34 PI 3-kinase is essential for protein sorting to the yeast lysosome-like vacuole. EMBO J 1993;15:2195-204.
35. Miller S, Tavshanjian B, Oleksy A, et al. Shaping development of autophagy inhibitors with the structure of the lipid kinase Vps34. Science 2010;327:1638-42.
36. Bachman KE, Argani P, Samuels Y, et al. The PIK3CA gene is mutated with high frequency in human breast cancers. Cancer Biol Ther 2004;3:772-5.